TW200716170A - Vaccine - Google Patents

Vaccine

Info

Publication number
TW200716170A
TW200716170A TW095114585A TW95114585A TW200716170A TW 200716170 A TW200716170 A TW 200716170A TW 095114585 A TW095114585 A TW 095114585A TW 95114585 A TW95114585 A TW 95114585A TW 200716170 A TW200716170 A TW 200716170A
Authority
TW
Taiwan
Prior art keywords
hpv
vaccine
protein
delivery
immunogenic fragment
Prior art date
Application number
TW095114585A
Other languages
English (en)
Inventor
Brigitte Desiree Alberte Colau
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/006461 external-priority patent/WO2005123125A1/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of TW200716170A publication Critical patent/TW200716170A/zh

Links

TW095114585A 2005-04-26 2006-04-24 Vaccine TW200716170A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67482905P 2005-04-26 2005-04-26
GB0509010A GB0509010D0 (en) 2005-05-03 2005-05-03 Vaccine
PCT/EP2005/006461 WO2005123125A1 (en) 2004-06-16 2005-06-14 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52

Publications (1)

Publication Number Publication Date
TW200716170A true TW200716170A (en) 2007-05-01

Family

ID=34674257

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095114585A TW200716170A (en) 2005-04-26 2006-04-24 Vaccine

Country Status (4)

Country Link
BR (1) BRPI0610032A2 (zh)
GB (1) GB0509010D0 (zh)
PE (1) PE20061320A1 (zh)
TW (1) TW200716170A (zh)

Also Published As

Publication number Publication date
GB0509010D0 (en) 2005-06-08
BRPI0610032A2 (pt) 2011-10-18
PE20061320A1 (es) 2006-12-29

Similar Documents

Publication Publication Date Title
MX2007013472A (es) Vacuna.
EP4219566A3 (en) Recombinant rsv antigens
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
WO2007030810A3 (en) Multiparameter whole blood monitor and method
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
WO2004080403A3 (en) Influenza virus vaccine
WO2007117303A3 (en) Combination vaccine comprising an attenuated bovine viral diarrhea virus
NZ529881A (en) Capsular polysaccharide solubilisation and combination vaccines
EP2491947A3 (en) Vaccine
GB0025577D0 (en) Vaccine
MY169275A (en) Method of immunization against the four serotypes of dengue
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
WO2007081896A3 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
EP2078083A4 (en) NEW DOG INFLUENZA VIRUS AND VEGETABLE THEREFOR
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
WO2003063899A3 (en) Vaccine adjuvant based on a cd4 0 ligand
WO2009085025A3 (en) System and method for sparql-query processing using parametrized-sparql-query in dbms-based systems
PL1949913T3 (pl) Immunostymulująca kombinacja do profilaktyki i leczenia wirusowego zapalenia wątroby typu c
WO2006007555A3 (en) Rotavirus antigens
WO2003059385A3 (en) Hiv vaccine and method of use
WO2004091524A3 (en) Respiratory virus vaccines
WO2007121491A8 (en) Hcv vaccinations
WO2004043404A3 (en) Process for designing inhibitors of influenza virus non-structural protein 1
TW200612983A (en) Vaccine